Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
Condition(s):Chronic Pulmonary Aspergillosis; AspergillosisLast Updated:October 30, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Chronic Pulmonary Aspergillosis; AspergillosisLast Updated:October 30, 2023Not yet recruiting
Condition(s):Pneumonia, Ventilator-AssociatedLast Updated:February 26, 2024Recruiting
Condition(s):Mild, Allergic AsthmaLast Updated:November 6, 2017Completed
Condition(s):Adenovirus; Cytomegalovirus Infections; Epstein-Barr Virus InfectionsLast Updated:January 11, 2024Recruiting
Condition(s):Femoral FractureLast Updated:February 20, 2024Recruiting
Condition(s):Primary DystoniaLast Updated:November 6, 2017Completed
Condition(s):COVID-19 Respiratory InfectionLast Updated:May 23, 2022Completed
Condition(s):mTBILast Updated:June 12, 2023Recruiting
Condition(s):Disorder of ConsciousnessLast Updated:December 7, 2022Recruiting
Condition(s):MelanomaLast Updated:December 16, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.